CRIS Current Research Information System

PICCI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.661
AS - Asia 3.930
EU - Europa 3.763
SA - Sud America 306
AF - Africa 285
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.606
SG - Singapore 1.272
CN - Cina 975
GB - Regno Unito 940
VN - Vietnam 857
DE - Germania 565
IT - Italia 547
SE - Svezia 521
HK - Hong Kong 409
RU - Federazione Russa 269
BR - Brasile 224
IN - India 199
IE - Irlanda 167
FR - Francia 164
UA - Ucraina 141
CH - Svizzera 101
ZA - Sudafrica 95
CI - Costa d'Avorio 89
NL - Olanda 88
EE - Estonia 65
KR - Corea 58
TG - Togo 58
BG - Bulgaria 49
JO - Giordania 49
JP - Giappone 45
AR - Argentina 38
BE - Belgio 35
FI - Finlandia 31
CA - Canada 29
ID - Indonesia 19
SC - Seychelles 19
PL - Polonia 18
ES - Italia 16
MX - Messico 15
AT - Austria 12
BD - Bangladesh 12
EC - Ecuador 12
GR - Grecia 11
CL - Cile 10
AU - Australia 9
TR - Turchia 9
PE - Perù 6
CO - Colombia 5
NG - Nigeria 5
UY - Uruguay 5
IQ - Iraq 4
IR - Iran 4
LT - Lituania 4
MA - Marocco 4
UZ - Uzbekistan 4
CR - Costa Rica 3
HR - Croazia 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
BY - Bielorussia 2
BZ - Belize 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
LB - Libano 2
NO - Norvegia 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
CM - Camerun 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 13.956
Salva come PNG Salva come JPEG
Città #
Southend 826
Singapore 821
Ashburn 624
Fairfield 620
Chandler 520
Hong Kong 407
Woodbridge 309
Wilmington 293
Houston 280
Seattle 266
Ann Arbor 263
Santa Clara 263
Cambridge 238
Dong Ket 233
Princeton 229
Beijing 170
Dublin 167
Boardman 142
Ho Chi Minh City 130
Hefei 126
Hanoi 117
Bern 92
Abidjan 89
Westminster 83
Nanjing 81
Jacksonville 78
Padova 77
Berlin 67
Los Angeles 64
Bologna 62
Lomé 58
Seoul 58
Turin 58
Amman 49
Sofia 48
Bremen 46
Buffalo 46
Saint Petersburg 44
Tokyo 44
San Diego 43
Hebei 38
Redondo Beach 37
Falls Church 35
Brussels 34
Jinan 34
Shenyang 33
Dallas 31
Milan 30
Nanchang 30
New York 30
Frankfurt am Main 28
Changsha 27
São Paulo 26
Guangzhou 25
Des Moines 24
Helsinki 24
Tianjin 23
London 22
Mülheim 22
Redmond 20
Falkenstein 19
Florence 19
Medford 19
Dearborn 18
Düsseldorf 18
Zhengzhou 18
Da Nang 17
Nuremberg 16
Olalla 16
Bengaluru 15
Haiphong 15
Jiaxing 14
Phoenix 14
Munich 13
Warsaw 13
Chicago 12
Hải Dương 12
Ningbo 12
Rome 12
San Jose 12
Amsterdam 11
Brooklyn 11
Jakarta 11
Redwood City 11
Shanghai 11
Toronto 11
Catanzaro 10
Haikou 10
Lauterbourg 10
Bühl 9
Chengdu 9
Ha Long 9
Kuban 9
San Francisco 9
Wuhan 9
Biên Hòa 8
Crocetta 8
Kunming 8
Las Vegas 8
Mahé 8
Totale 9.298
Salva come PNG Salva come JPEG
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 277
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. 220
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 217
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 205
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. 204
Spontaneous healing of an osteochondroma fracture. 200
CD99 Acts as an Oncosuppressor in Osteosarcoma. 200
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. 194
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 194
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 188
Clinical outcome of central conventional chondrosarcoma. 181
Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). 173
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 170
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 169
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 168
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. 166
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 166
Osteosarcoma follow-up: chest X-ray or computed tomography? 165
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases 163
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 162
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 162
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 160
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 160
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 159
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 158
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 156
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 153
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 151
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 151
Second malignancy in 597 patients with Ewing Sarcoma of Bone treated and a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 148
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 147
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 145
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 144
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 141
Adjiuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group 137
Small cell osteosarcoma: Clinicopathologic, immunohistochemical, and molecular analysis of 36 cases 137
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 137
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 136
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 136
The natural history of advanced inoperable central chondrosarcoma 135
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 134
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 133
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 133
NVE-BEZ235 as a new therapeutic option for sarcomas. 133
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 133
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 132
Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant chemotherapy between 1972 and 1999 130
Molecular diagnosis in ewing family tumors the rizzoli experience-222 consecutive cases in four years 129
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 129
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 128
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 128
Sarcomi delle parti molli. Tredici anni di esperienza dell'Istituto Ortopedico Rizzoli - Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute. 126
Osteoblastoma-like osteosarcoma: high-grade or low-grade osteosarcoma? 126
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 124
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis 123
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Grouo/Scandinavian Sarcoma Group III protocol 123
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. 123
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 122
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 121
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 121
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 119
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 119
Advances in Bone Metastases Management 118
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 118
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. 118
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 117
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 116
Genetic and Molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes. 115
Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature 115
Palliative therapy for osteosarcoma. 114
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 114
Pediatric chondrosarcomas: a retrospective review of 17 cases 113
Molecular alterations of monophasic synovial sarcoma: Loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity 113
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 112
Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study 111
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 108
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 107
Osteosarcoma teleangectasico: analisi clinico-patologica di 87 casi 106
Epidemiology 106
Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. 103
Primary metastatic Ewing's family tumors:results of the Italian Sarcoma Group And Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. 102
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas 102
Inflammation and infiltration: can the radiologist draw a line? MRI versus CT to accurately assess medullary involvement in parosteal osteosarcoma 102
Platelet-derived growth factors enhance proliferation of human stromal stem cells 100
Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients 99
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results 98
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction 97
Reconstruction in the treatment of pelvic chondrosarcoma. 96
Evoluzione dei trattamenti integrati nei sarcomi dei tessuti molli all'Istituto Ortopedico Rizzoli 96
Imaging of bone tumours for the musculoskeletal oncology surgeon. 94
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 94
null 92
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors. 92
Palliative treatment: selective arterial embolisation for bone metastases. 88
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? 88
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series 88
Dedifferentiated chondrosarcoma: preliminary results from the European Bone over 40 sarcomas study, (EURO.B.O.S.S.) 85
Sacral Chordoma: Long-term outcome of a large series of patients surgically treated at two reference centers 84
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature 84
Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, retrospective, multicenter study of the italian sarcoma group 82
Totale 13.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021918 0 0 0 0 0 55 35 92 111 80 57 488
2021/20221.916 160 56 125 136 185 123 46 139 67 176 391 312
2022/20232.258 227 283 123 300 142 144 74 142 387 69 183 184
2023/2024479 23 107 41 37 22 75 40 40 14 26 23 31
2024/20252.212 106 354 191 135 388 99 132 77 19 169 76 466
2025/20262.695 480 568 435 386 576 250 0 0 0 0 0 0
Totale 14.226